[Update on tirofiban].
Hôpital Georges Pompidou, Paris.
N
N
Danchin
D003327:Coronary Disease / Q000188:drug therapy; D005602:France; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000145:classification / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D017410:Practice Guidelines as Topic; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000145:classification / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077466:Tirofiban